Pancreatic Islet Cell Transplantation Act of 2003
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Establishes the Interagency Committee on Islet Cell Transplantation within the Department of Health and Human Services (HHS). Requires the Committee to study related issues, including Federal research funding, the effect of specified policies on transplantation, and data collection.
Instructs the Secretary of HHS to request the Institute of Medicine to provide a study of the impact of islet cell transplantation on juvenile diabetes patients, including their health and the treatment's cost-effectiveness.
Directs the Secretary, acting through the Administrator of the Centers for Medicare & Medicaid Services, to establish a demonstration project to assess the efficacy of pancreatic cell islet transplantation for individuals who: (1) have Type I (juvenile) diabetes; and (2) have end-stage renal disease; and (3) are Medicare beneficiaries. Establishes reporting requirements.
Referred to the Subcommittee on Health.
- Introduced in House Formatted Text PDF
Cite this page
U.S. Congress. (2026). H.R. 1068: Pancreatic Islet Cell Transplantation Act of 2003. 108th Congress. Open America. https://openamerica.io/bill/108-HR-1068/
"H.R. 1068: Pancreatic Islet Cell Transplantation Act of 2003." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-HR-1068/.
H.R. 1068, 108th Cong. (2026), https://openamerica.io/bill/108-HR-1068/.
[H.R. 1068: Pancreatic Islet Cell Transplantation Act of 2003](https://openamerica.io/bill/108-HR-1068/)